In this work, DoE was explored to rapidly and accurately reveal the most favorable BSA-coated TMZ-WRAP5/p53 gene-based plasmid DNA complexes for drug/gene co-delivery toward glioma cells. The gene discussed is TP53; the disease is central nervous system cancer.